Menon Biosensors, Inc.

16550 West Bernardo Drive
Bldg 5, Suite 525, CA 92127-1870 USA
Phone
Fax
Click for website

Research Sector Infectious Disease

Summary Description Molecular biochemistry company analyzing for rapid detection and diagnosis of biological pathogens.

Management Suresh Menon, PhD., Founder and President; Gregory P Hanson CMA, MBA, Acting CFO/Advisory Board Member; David Schlotterbeck, Chairman Advisory Board

Click here for Financial Data
Keywords: infectious disease, biological pathogens, diagnostics device, assays, nuclear magnetic resonance, NMR, molecular mirroring M(2) technology

Comment


Updated: Apr. 05, 2016


Description

Microfluidics and M2 NMR platform technology (classified by the U.S. Government until 2012) provides superior sensitivity and specificity and minimizes sample preparation, providing best in class samp......view more

Products / Services

Portable biosensor and assays detect a variety of biological pathogens. The robust platform technology enables Menon to develop new assays for serious worldwide diseases in just 60 to 90 days, while ......view more

Technology / Differentiation

M(2) (Molecular Mirroring) nuclear magnetic resonance (NMR) technology has been validated through multiple studies with the U.S. government's Bio-defense Program. In these studies, in more than 3,000 ...view more

Market / Customers

Healthcare Diagnostics; Food and Water Safety Testing Healthcare/Food safety/livestock testing - Menon Biosensor provides accurate results in less than one hour from the time a sample is collected.......view more


Revenue / Funding

Funding to Date: $20 MM Financing Sought: $30 MM...view more

Status

SAN DIEGO, January 9, 2014 Menon Biosensors, Inc. a molecular biochemistry company that provides DNA analysis for the diagnosis of biological pathogens, announced today that its M2 (Molecular Mirror...view more

Advisors

Law Firm: DLA Piper, LLP Banker: Healthios Accounting Firm: Swenson Advisors LLP, Certified Public Accountants...view more

RELATED COMPANIES